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One approach to  the problem of the biological function of complement is 
the comparative study of this strange and unstable complex as it occurs in the 
sera of different species of animals.  The first of two recent studies along these 
lines was  that of Hegediis and  Greiner (1).  The reasonable hypothesis was 
propounded that the titer of a complement is limited by the component present 
in lowest titer, and that each of the four components might be titrated inde- 
pendently by addition of the other three components in excess, so as to make the 
component in  question  the  one present  in  lowest titer.  Required  reagents 
were prepared by standard methods from guinea pig complement, apparently 
in  the firm conviction that  each  component of this  complement was wholly 
equivalent in function to the corresponding component of the complement of 
the animal species being tested, and vice versa.  The validity of this assumption 
was denied by Ecker, Pillemer, and Seifter in a comparative study of human and 
guinea  pig  complements  (2)  because  certain  substitutions  were  not  found 
"effective." 
The complements of these  two  species have been  under investigation for 
several years in  the laboratories of the Presbyterian  Hospital  (3-8,  and  un- 
published studies).  While there had been no reason to question  the assump- 
tions underlying the work of Hegediis and Greiner, doubts had arisen as to the 
adequacy of their technique for measuring the various  components and their 
conclusions as to the relative quantities of the components in  guinea pig com- 
plement had not been confirmed.  It also became evident that experimental 
conditions could be found under which the components of human and guinea 
pig complements are mutually substitutive  1 and that existing methods for the 
titration of the components of complement required revision in order to render 
them suitbd to their purpose.  It was therefore decided to submit evidence on 
these matters already in hand and to extend the study in order to learn more 
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1  Ecker, Pillemer, and Seifter have now independently concluded  that the components  are 
equivalent (private communication  from Dr. Ecker). 
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of the part played by each component in the fixation of complement in general 
and the uptake of complement nitrogen by specific precipitates in particular, 
problems still in large measure unsolved in spite  of  early  (9,  10)  and more 
recent studies (8,  11-13). 
Accordingly, estimations were made of the titers of the components present 
in  "midpiece,"  "endpiece,"  and  in  the  so  called  "specifically inactivated" 
complements (11) prepared by different methods, since this was a prerequisite 
to an understanding of these reagents and to their use in quantities adequate to 
provide, in optimal excess, the components desired. 
The greatest care has been taken in the present studies to use each reagent 
well  below  its  anticomplementary range.  Emphasis  on  this  rudimentary 
precaution appears indicated by the lack of any positive evidence that it was 
observed  in numerous recent investigations. 
The data herein reported are given in some detail since fundamental prin- 
ciples and procedures are involved.  It is felt that  due consideration of the 
data and discussion will aid in dispelling some of the confusion surrounding the 
subject of the components of complement. 
EXPERIMENTAL 
Methods and Materials 
Complement--Blood from healthy guinea pigs was obtained by cardiac puncture without 
anesthesia.  Human blood was taken by venous puncture.  After about 1 hour  at room 
temperature,  the  serum was drawn  off, centrifuged, and used either  on the  same day or 
stored, tightly-stoppered, in a dry-ice freezer until needed.  Complement preserved in this 
way did not lose activity even after several months' storage, although prolonged exposure 
to CO2 sometimes lowered the pH, necessitating addition of 0.1 N NaHCO3 to pH 7.5 or 8. 
Sheep Red Cells and Hemolysin.--Defibrinated blood was obtained  once a  week, alter- 
nately from each of two sheep.  The red cells were washed 4 times, and a 5 per cent suspen- 
sion containing  about  125  million erythrocytes  per  0.1  ml. was sensitized with  an equal 
volume of a rabbit anti-sheep cell hemolysin dilution containing about 4 "units" (estimated 
in the usual way with excess complement) per 0.1 ml.  0.2 ml. of sensitized red cell suspen- 
sion was employed in each test; that is, roughly 125 million red cells sensitized with 4 "units" 
of hemolysin. 
Hemolytic Titer.--This was estimated  by addition of varying quantities of a dilution of 
complement, reagent, or component to 0.2 ml. portions of the sensitized red cell suspension 
and addition of saline, if required, to make a total volume of 0.6 ml.  In instances in which 
relatively large volumes of reagent were necessary volumes up to 0.8 ml. could be used with 
little influence on the end result.  The tubes containing the mixtures were incubated in a 
water  bath at 37-38°C. for 30 minutes, with  shaking every  10 minutes.  The number of 
hemolytic units per milliliter of undiluted serum was calculated by dividing the dilution em- 
ployed by the smallest volume giving complete hemolysis.  For the estimation of single com- 
plement  components  in  whole, fractionated,  or  "specifically inactivated"  complements, 
titrations were carried out in the  presence of a  constant optimal quantity of the proper 
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Preparation of the Reagents.  A.  "Midpiece"  (M) and "Endpiece" (E).--Fractionation  of 
complement was carried out by dialysis or dilution following Ferrata  (14),  Liefmann  (15), 
and later workers (2,  11).  The dilution method took less  time, and sometimes gave better 
recoveries of C'22 and  C'4 in E. 
1. Dilution Method.--To  10 volumes of chilled ~/200 KH~PO, solution, 1 volume of chilled 
guinea pig (g.p.)  or human  (hu) serum was added slowly,  with constant mixing in the cold. 
The pH of the mixture approached neutrality.  After 20 to 30 minutes at 0°C., the precipi- 
tate was centrifuged off in the cold, separated as completely as possible from the supernatant 
and, in the case of g.p. C? washed with phosphate solution of approximately the same ionic 
strength and pH as the final value.  The precipitate from hu C' was  not  washed  since  hu 
serum contains much less C'2.  The preciptate, or "midpiece," was dissolved in saline, usually 
with addition of 0.1 N NaHCO3 until neutral, and made up  to 5 times original serum volume 
for further dilution as needed.  The original supernate, "endpiece," was made isotonic with 
10 per cent NaC1 and neutralized with 0.1 ~ NaHCO3 as soon as possible,  since C'2 is unstable 
below pH 6.5  (16,  17).  The final dilution was  1:12.  In the fractionation of g.p.  C', the 
COs dilution method (15) was used in numerous instances as well. 
2. Dialysis  Method.--Directions  in  (2)  were  followed with  several  modifications.  The 
period of dialysis was shortened to 6 hours when 5 ml. portions of serum were used, to avoid 
deterioration of components unstable in the acid pH range.  This was accomplished by in- 
creasing the dialyzing surface by placing a Pyrex test tube inside the cellophane bag to force 
the serum into the resulting annular space and by changing the outside buffer solution every 
2 hours and mixing frequently.  The final dilutions were 1:5 for M and 1 : l0 for E. 
B.  Sera Lacking Either C'3 or C'4.--The preparation of human or guinea pig complement 
Jacking in  one of the  two  relatively heat-stable  components was carried  out according to 
(2, 18, 19) with little modification, confirmation being obtained of the necessity for inactivat- 
ing C'3 with "zymosan" (18) at slightly alkaline reaction.  About 15 times as much zymosan 
was required for the inactivation of g.p.  C'3 as for hu C'3.  The optimal period for the C'4 
inactivation with ammonia was  1 hour. 
C. Heat-Inactivated Serum.--Hu and g.p.  sera were heated at 56°C.  for 20 minutes, this 
being sufficiently long to inactivate C'I and  2 and less destructive for C~3 and  4  than  30 
minutes' heating.  In every instance in which this reagent was used, 0.05 or 0.1  ml. of 1:5 
dilution was employed. 
D. Sera Possessing Activity  of a Single Complement Component.--By  treating heated hu 
and  g.p.  sera with either ammonia or zymosan  (2,  18), reagents  were obtained  with  the 
single  reactivity of C'3 or C'4.  When C'I alone was wanted,  "midpiece" from sheep serum 
sufficed (cf. 1). 
Titration of the Four Components of Complement 
A  reagent  for  the  titration  of  a  given  component  should  not  contain  the 
component to be fitrated,  but should contain an excess (i.e.,  >  1 unit perdose 
employed)  of each of the remaining  components.  Four reagents are required 
(cf.  1): reagent  1,  containing C'2, 3, 4, for the titration of C'I; reagent 2,  con- 
raining C'I, 3, 4, for the titration of C'2; reagent 3  with Cq,  2, 4, for the titra- 
tion  of C'3;  and  reagent  4,  containing  C'I,  2,  3,  for  the  titration  of Ct4.  A 
In agreement with Ecker and Pillemer complement is designated C' and the components 
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reagent should produce no lysis of sensitized red  cells  when used  alone in 
several times the quantity employed in actual titrations. 
Reagent 1 was prepared by combination of E, which furnishes C'2 and some 
C'3 and C'4, with heated serum which supplies extra C'3 and C'4.  Reagent 2 
consisted of M  plus heated serum.  In each instance the heated serum was 
added separately to the types in which the tests were carried out.  Zymosan- 
treated C' (2,  18) was employed as reagent 3, while ammonia- or hydrazine- 
treated C' served as reagent 4. 
For purposes of control, the adequacy of each reagent should be established 
by experiment, a condition which was not adequately met in (1, 2, etc.)  This 
requires  testing each  reagent  (R)  with every other reagent,  as  follows:  (a) 
R1 +  R2; (b) R1 +  R3; (c) R1 +  R4; (d) R2 +  R3; (e) R2 +  R4; (f) R3 + 
R4.  If complete hemolysis of added sensitized red cells follows, the first test 
demonstrates the presence  of 1 or more units of C'2  in  the  amount of R1 
used, and one or more units of C'I in R2.  Similarly, the second  test estab- 
fishes the presence, in adequate amount, of C'3 in R1 and C'I in R3.  If all 
tests result in complete hemolysis, it is certain that each of the four reagents 
actually contains the three components which it is designed to supply.  While 
it is desirable to perform a  complete test with every set of reagents, this was 
not always done in the titrations described below, in some of which control 
tests for critical components, only, were included. 
Below  the  anticomplementary limit  (see  next section),  the  quantity of a 
reagent should be chosen in a  range in which the titer of the component re- 
mains independent of the amount of reagent employed.  The complete quan- 
titative composition of the reagents was not established in every experiment. 
It  is,  however,  possible to  give the  composition of average preparations  of 
each reagent from data gathered in the course of the work, as noted in the 
subsequent  sections.  For  example,  "endpiec~"  (E),  which is  used  in  R1, 
showed the following average  composition:-- 
Source and method of preparation  C'2 titer  Ct3 titer  C'4 titer 
Hu, dialysis 
"  dilution 
G.p., dialysis 
"  dilution 
uniIs/mL 
11o 
115 
14o 
220 
unils/ml. 
35 
45 
6O 
6O 
unils/rM. 
2400 
24OO 
35OO 
2100 
It is evident that E  is generally deficient in C'3, since less than 100 units are 
present per milliliter and 0.1 ml. of a  1/10 dilution (the amount generally em- 
ployed) contains <  1 unit of C'3.  The addition of heated complement, by 
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hu E.  G.p. E  +  heated g.p. serum yielded the best R1, since g,p. E  contains 
more  C'2  than hu E,  and heated  g.p.  serum is not anticomplementary  and 
supplies more C'3 than heated hu serum. 
Guinea pig C' inactivated for 20 minutes at 56°C. usually titered 100 to 300 
units of C'3 and about 500 to 2000 units of C'4.  The C'4 titer of heated human 
serum was similar, but the C'3 content was very low. 
The average composition of "midpiece" (M) follows:-- 
Source and method of preparation 
Hu, dialysis 
"  dilution 
G.p., dialysis 
"  dilution 
C'I fiter 
units/mL 
1000 
1000 
350 
C'3 titer 
unlts/ml. 
90 
40 
120 
I00 
C'4 titer 
unlts/mL 
350 
130 
100 
Again it is seen that M  should be combined with heated complement for use 
as R2, owing to its deficiency of C'3 and often of CI4 as well.  This  appfies 
especially to hu  M,  which  was preferred for R1  since  it  is not  anticomple- 
mentary.  G.p. M, when freshly prepared, should not be anticomplementary, 
but often becomes so if kept in solution,  or if made alkaline. 
Average Composition of Zymosan-Treated Complement 
Source 
Hu 
G.p. 
C'I titer 
unlts/mL 
2OOO 
1000 
C'2 titer 
unlts/mL 
IO0 
260 
C~4 titer 
units/ml. 
200O 
2O0O 
If at least 0.02 ml. (0.1 ml. of 1:5 dilution) is used, this reagent functions as 
R3. 
Average Composition of Ammonia-Treated Complement 
Source  CJ1 titer  C'2 titer  C'3 titer 
unitslml,  unltslmL  units/ml. 
Hu  2000 
G.p.  1200  300  100 
Anticomplementary  Action  of the  Reagents.--The  anticomplementary effect 
of  g.p.  "midpiece",  when  encountered,  was  found  to  be  somewhat  greater 
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G.p.  Madded 
Dilution*  MI. 
0 
1:5  0.15 
0 
1:100  0.15 
0.15: 
0 
1:50  0.1 
0.3 
0 
1:5§  0.05 
o.o51 
ml., 0.05 
ml., 0.08 
+ 
+++ 
ml., 0.05 
4- 
mL, 0.05 
+ 
+++.4- 
G.p. C' (1:40) 
0.1 
++4- 
-4- 
C 
0.18 
C 
+ 
0.15 
C 
+4- 
C 
0.05 
++ 
0.08 
+ 
4- 
+++ 
Hu C' (1:10) 
0 
+ 
0.08  0.13 
+++4-  e 
+  +++ 
+  ++ 
0.1  0.2 
+++4-  c 
+++  c 
C  C 
0.05 
4- 
0.05 
+ 
+++4- 
0.1 
++4- 
ac 
c 
0.1 
C 
+ 
0.15 
C 
C 
C 
0.13 
C 
C 
0.2 
C 
C 
C 
In this and subsequent protocols -- to +  +  to c indicates degree of hemolysis.  ++  + 4- 
=  a few red cells left; ac =  faint haze; c =  complete, crystal-clear hemolysis. 
* Based on volume of original g.p.  serum used for preparation  of reagent.  A  different 
preparation of M was used in each of the experiments. 
:~ Plus 0.05 ml. of 1 : 5 dilution of heated g.p. serum, to complete R2. 
§ Freshly prepared by dialysis; neutralized, but not made alkaline. 
H  Plus 0.08  ml. of 1:5 heated g.p.  serum. 
Addition  of heated  g.p.  serum  greatly reduced  this  anticomplementary  ac- 
tion of g.p., hu, and sheep M,  the only ones tested. 
Hu  M  is  seldom  anticomplementary  toward  hu  C'  but  may  be  toward 
g.p.  C':-- 
Hu M  sdded 
Dilution  MI. 
0 
1:5  0.05 
0.05* 
1:5  0005 
0.05" 
ml., 0.08 
++ 
+++ 
C 
+ 
+ 
+4- 
Hu C' (1:I0) 
0.1 
ac 
ac 
c 
+++ 
0.13 
C 
C 
C 
0.08 
++-4- 
++ 
ac 
+ 
4- 
C 
G.p. C' (1:40) 
0.1 
C 
+++ 
C 
0.13 
C 
C 
C 
C 
++± 
C 
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TABLE I 
Titration of C'I in Hu and G.P. Complements 
Human 
Sample 
Pool 1 
"  2 
"  2 
"  3 
"  3 
"  4 
Individual, 1 
"  2 
"  2 
"  2 
"  3 
"  3 
"  4 
"  6 
"  7 
"  8 
"  8 
"  9 
Dilu. 
tion 
1 to: 
4OO 
300  i 
30O 
3OO 
30O 
20O 
200 
3OO 
3O0 
300 
5O0 
5OO 
3OO 
500 
30O 
3OO 
4O0 
4OO 
200 
Reagent 
G.p. E  +  heated 
g.p. serum* 
G.p. E 
R1 
G.p. E 
R1 
R1 
Hu E 
"  "+  heated 
hu serum 
Hu  E  +  heated 
g.p. serum 
G.p. E 
R1 
G.p. E 
R1 
gc 
Hu  E  +  heated 
g.p. serum 
R1 
Guinea pig 
Sample 
Individual, 1 
"  1 
Pool 1 
"  X 
"  2 
"  2 
"  ] 
"  ] 
"  4 
"  4 
"  5 
"  5 
"  6 
"  7 
"  8 
"  8 
"  9 
"  10 
C'I 
titer 
units/ 
ml. 
undil. 
C' 
1300 
1300 
1300 
2O00 
1200 
1500 
40O0 
40OO 
1000 
20OO 
27OO 
2700 
6O0O 
1000 
1300 
1300 
1500 
7OO 
* 0.05 ml. of 1:5 heated g.p. serum to complete R1. 
Hu  and g.p. C' treated with zymosan were not anticomplementary  nor was 
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anticomplementary toward g.p.  serum, but not against hu serum, g.p. E,  or 
heated g.p.  serum. 
Titration  of the Four  Components in Human and Guinea Pig Complements 
and  the Reagents Prepared from  These.--With  the  limits  established  within 
which  tile various reagents might be used,  titration  of the four components 
was now possible. 
1.  Titration  of First Component, C'l.--Complement dilutions most suitable 
for titration  of C'I were found  to be between  1:200  and  1:500.  Increasing 
amounts  were  set  up  with  an  amount  of reagent  1,  usually  between  0.2  to 
0.5  ml.,  previously  found  to  contain  an  optimal  excess  of  C'2,  3,  and  4. 
Reagent 1, prepared by use of a volume of g.p. E  such as given above, and 0.05 
ml. of 1:5 heated g.p. serum, was found preferable to that from hu E, as with 
the  latter,  amounts  up  to  1  ml.  were  sometimes required,  and  anticomple- 
mentary activity was also encountered.  However, as noted at the bottom of 
Table I, comparable Cq  titers  could be obtained  with  either reagent under 
favorable  conditions  (freshly prepared  hu  E).  As  prepared  and  used,  g.p. 
R1  usually  contained  about 3 units of C'2, 3  of  C'3,  and  50  to  100  of  C'4. 
Cq  titrations of  hu and g.p.C'  are  reported  in  Table  I.  Numerous  other 
samples were tested, with results in the same range. 
For the titration of C'I in "midpiece" a  dilution of about 1:100 was found 
comvenient.  Again, g.p. R1 was the reagent of choice although similar results 
could be Obtained,  but less readily owing to a deficit of C'2, by substitution 
of hu E  for g.p.E.  Heated hu  serum could also be substituted  for heated 
g.p. serum. 
Titration of hu and g.p. M  with R1 :-- 
"Midpiece" 
1:100 
Hu 
c~ 
G.p. 
Method of preparation 
Dilution 
Dialysis, pH 5.4 
"  pH 6.7 
Dialysis 
Dilution 
C'I titer 
Original C'  M 
unlts  / ml.  units  /ml. 
6700  1600 
6000  1500 
2000  500 
2000  1000 
2000  1000 
1300  350 
700 ,J  200 
1200  700 
Recovery 
per cent 
(25) 
25 
25 
50 
50 
25 
30 
6o 
The C'I  titrations carried  out on  zymosan- and ammonia- or hydrazine- 
treated sera showed  that  these inactivation procedures  for C'3 and  C'4,  re- 
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TABLE  II 
Titration of C'2 in Hu and G.P. Complements 
Human  Guinea pig 
Titer  Titer  Dilu-  Reagent  Dilu-  Reagent added for  Sample  tion  added for C'2  Sample  tion  C'2 titration only  used  Whole  used  titration only Whole  C'  C'2  CI2 
units/  units/  1 to:  units/  units~ 
1 to:  ml.  ml.  ml.  ml. 
Pooled  20  G.p.  M*  +  heated  80  160  Pooled  40  Hu M  +  400  50C 
heated g.p. serum  heated 
G.p.  M*  +  heated  80  g.p. 
hu serum  serum 
(R2) 
20  Hu M  +  heated g.p. i  100  130: 
serum (R2)  "  40  R2  300  400: 
Sheep M  +  heated  130 
g.p. serum  "  40  "  270  300: 
G.p.  M  +  heated  130 
g.p. serum  "  40  "  300  400 
"  20  R2  100  200:  "  40  "  200  400 
Individual  20  "  80  200  "  40  "  270  500 
"  20  "  100  130  "  40  "  300  500 
"  20  "  80  130:  "  40  "  300  400 
"  20  "  100  200:  "  40  "  500  500 
"  20  "  70  80  "  40  "  270  270 
"  20  "  80  80  "  40  "  400  400 
"  20  "  130  200:  "  40  "  300  800 
"  20  "  130  240: 
"  20  "  100  100 
* M  =  "midpiece." 
:~ The same titer was obtained by addition of heated g.p. serum without "M," since suf- 
ficient C'I was present in the C' tested. 
as  well.  As  will  be  seen  later,  the  titers  of  all  remaining  components  are 
reduced. 
Titration  of  zymosan-  and  ammonia-  (or  hydrazine-)  treated  sera  with 
RI:-- Source 
G.p. 
Hu 
c¢ 
G.p. 
¢c 
Hu 
$g 
Inactivation by 
Zymosan 
~c 
Ammonia 
¢c 
Hydrazine 
Ammonia 
l¢ 
in C' used 
unlts/rnl. 
4000 
67OO 
2000 
2700 
2000 
27OO 
2000 
looO 
C'I  titer 
in reagent 
unlts/ml. 
1000 
5000 
1500 
1300 
1000 
1300 
2000 
400 
Recovery 
25 
75 
75 
50 
50 
50 
100 
40 
2.  Titration of C'2.--R2, for the titration of C'2, was preferably composed of 
hu M,  in  amounts of  0.025 to 0.1  ml. of a  1:5 dilution, plus 0.05 ml. of 1:5 
heated  g.p.  serum.  As  so  prepared,  the  amounts  used  contained  5  to  20 
units of  C'I,  2  to  3  of C'3, and  5  to  10  of  C'4.  R2  prepared  with  non- 
anticomplementary lots of g.p.  M  may also be employed.  Titration of  C'2 
in  whole  C'  may  be  carried  out  with  heated  g.p.  serum  alone,  since  C t 
Contains excess Cq.  However, for titration of C'2 in E, the complete reagent, 
R2, is necessary.  Representative data are given in Table II.  Taken with the 
other data given, it is evident that  C'2 is  the component  of  lowest titer in 
hu C', and hence the titer-limiting component. 
Sheep M  plus heated g.p. serum is also useful as R2.  Several protocols of 
ti.trafions of C'2 in "endpieces"  are reported below, followed by a summary of 
numerous titrations in Table III:-- 
"Endpiece" 
and dilution 
used 
Hul 
1:12 
Hu 2 
1:12 
G.p. 1 
1:48 
G@. 2 
1:24 
G.p. 3 
1:48 
Reagent: heated g.p. serum plus 
hu M  (R2) 
**nits of C'I 
added 
3 
3 
4.5 
6 
7.5 
1-7 
2.5-5 
0.05 
0.10 
0.10 
0.15 
0.2 
0.25 
0.05 
O. 05-0.035 
0.22-0.44 
sheep M 
units of C'l  rot. 
added 
1  0.05 
3-5  0.15-0.25 
7  0.35 
2.5-5  0.05-0.1 
C'2  tlter 
unCts/ral. 
30* 
40 
30* 
40 
120 
160 
160 
1205 
160 
480 
240 
48O 
320~ 
240 
240 
* Heated g.p. serum was not added in these two instances. 
Shows anticomplementary effect of excess reagent. 
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TABLE III 
T~tration of C'2 in "Endpieces"  with Reagent 2 
459 
Source 
Hu 1 
"  2 
"  1 
"  2 
tt  tt 
"  3 
tt  4 
G.p. 1 
"  1 
"  2 
"  3 
"  4 
"  5 
"  6 
Method of preparation 
Dialysis, pH 5.4 
"  pH 5.4 
"  pH 6.6 
"  pH 6.6 
Dilution 
tt 
tt 
Dialysis, pH 6 
Dilution 
tt 
tc 
Dialysis, pH 6 
tt 
C'2 titcr 
in C' used  in E 
uni~/ml,  uni~]ml. 
130  100 
130  90 
130  130 
130  110 
130  90 
270  200 
270  160 
270  130 
270  169 
400  160 
800  650 
320  240 
270  130 
27O  150 
Recovery 
~er cent 
75 
7O 
IO0 
85 
7O 
75 
6O 
5O 
6O 
4O 
8O 
75 
5O 
55 
It  is  clear  from  the  various  combinations  used  in  the  titrations  for  C'I 
and C'2 that hu and g.p. C'I are mutually substitutive and that the same ap- 
plies to C'2. 
After treatment of C' with zymosan or ammonia, or hydrazine, a reduction 
of C'2 activity occurred along with the elimination of C'3 or C'4.  Reduction in 
C'I  titer has  already been noted.  From the one instance  in  which  freshly 
boiled  zymosan was  used,  the  value of this precaution  (18)  seems  evident. 
The data follow:-- 
Effect of Zymosan or NH3 Treatment on C'2 Titer of C' 
Source 
Hu 
t~ 
G.p. 
~t 
c,t 
~t 
~f 
Inactivation  by 
Zymosan* 
Ammonia 
Zymosan 
Ammonia 
~t 
Hydrazine 
in C' used 
uni~/ml. 
130 
100 
530 
400 
530 
400 
4OO 
400 
530 
C'2 titer 
in reagent 
units  /ml. 
IO0 
<  5O 
270 
25O 
4OO 
320 
20O 
2O0 
2OO 
Recovery 
p~  ¢~'ttt 
75 
<  5O 
5O 
6O 
75 
8O 
5O 
5O 
4O 
* This was the only instance in which freshly boiled zymosan was used.  C'2 recovery 
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TABLE IV 
Titration of C'3 in Hu and G.P. Complements 
Dilution for C'3 
titration 
1 to: 
50 
25 
25 
25 
25 
25 
25 
25 
20 
20 
20 
Human  Guinea pig 
Titer  Titer 
Whole  C' 
unlts/ml. 
80 
100 
80 
100 
70 
100 
100 
80 
80 
100 
70 
C'3 
Dilution for C'3 
titration 
Whole C' 
unlts /ml. 
350 
200 
350 
350 
250 
>200 
250 
200 
130 
270 
> 130 
I to: 
60 
50 
40 
40 
40 
40 
40 
40 
40 
40 
40 
unlts/ml. 
500 
40O 
400 
4OO 
550 
200 
300 
550 
270 
400 
300 
C'3 
unlts/ng. 
600 
35O 
300 
400* 
550* 
200 
400 
550 
300 
400 
3O0 
* Same titer with fresh hu R3. 
3.  Titration  of C'3.--R3,  optimal for this titration, was prepared by treat- 
ment of g.p. C' with zymosan (2) according to (18), although the corresponding 
reagent from hu C' was also used in some instances.  0.05 mL of 1:5 dilution 
(based on  the g.p.  C' used)  appeared optimal for  the titration of C'3  in hu 
C' and  0.I  ml. of the same dilution for the titration in g.p.  C'.  The former 
quantity of reagent contained roughly 10 units of Cq,  2 to 3 of C'2, and 20 of 
C'4.  Results are recorded in Table IV from which it is evident that  C'3  is 
the  titer-limiting component  of g.p.  C',  although  the  titers of  C'2  are only 
slightly higher  (Table II). 
Titration for C'3 was carried out in M, E, and in ammonia-treated, and heat- 
inactivated sera. 
Titration for C'3 in "Midpieces" 
Source 
Hu 
~c 
~c 
~t 
G.p. 
~c 
Method of preparation 
Dilution 
cl 
Dialysis 
"  .(pH 6) 
Dialysis, pH 5.4 
"  pH 6 
Dilution 
C'3 titer 
Original C'  M 
units/ml,  units/ral. 
200  50 
200  30 
200  100 
200  100 
200  30 
270  100 
270  100 
400  170 
270  100 
Recovery 
~er tens 
25 
15 
50 
50 
15 
35 
35 
40 
35 Titration for C'3 in Hu and G.P. "Endpieces" 
Source 
G.p. 
tt 
Hu 
it 
:Method  of preparation 
Dilution 
Dialysis, pH 5.4 
"  pH 6.6 
6 hrs. dialysis, pH 5.4 
Dilution 
Dialysis, pH 6.6 
"  pH 5.4 
C'3 titer 
Ordinal C'  E 
units/ml,  units/ml. 
270  60 
270  30 
270  100 
400  40 
200  30 
200  60 
200  30 
200  40 
Recovery 
per cen~ 
20 
10 
35 
10 
15 
30 
15 
20 
Titration for C'3 in Ammonia- or Hydrazine-Treated G.P. Sera 
C'3 titer 
Source 
G.p. 
~t 
Original C' 
units/ral. 
5,30 
320 
200 
2OO 
270 
NHrtreated sera 
uni~/ml. 
20O 
130 
8O 
100" 
130 
Recovery 
per cent 
40 
4O 
40 
50 
5O 
* Serum  treated  with  hydrazine. 
Heat-inactivated  g.p.  C'  also  contains  less  C'3  than  the  original  C',  as 
shown  below:-- 
C'3 titer 
Original C'  After 20 minutes at 560C. 
units  /ml. 
400 
320 
270 
320 
units/rat. 
270 
200 
130 
250 
Recovery 
per cen~ 
70 
60 
50 
80 
The C'3 content of heated, NHa-treated g.p. serum was also studied.  After 
heating at 56°C. for 20 minutes, the samples were cooled in ice water and treated 
with ammonia in the usual way.  This reagent should contain only C~3 in an 
active state:-- 
C'3  titer 
Original C' 
uni~/ml. 
320 
320 
530 
C'3 
unlts/ml. 
100 
70 
100 
Remaining C'3 activity 
p~r cent 
30 
2O 
20 
461 462  HUMAN  AND  GUINEA  PIG  COMPLEMENTS  AND  COMPONENT  FRACTIONS 
CP3 from human C' was also prepared, but its titer was only 20 units per ml. 
when  tested  with  zymosan-treated  hu  C t,  and  it  was  anticomplementary 
toward g.p. C'. 
4.  Titration  of  Ct4.--R4  consisted  preferably  of  ammonia-treated  g.p. 
C p since  the  corresponding  reagent  from  hu  C'  was' anticomplementary  (cf. 
also (2))  and  contained too little C'2 and 3. 
Usually 0.2  ml.  of R4  at  1:10  dilution  was  used,  the  component  content 
being 20  to 30  units of C11,  6  of C'2,  and  2  of CI3.  The data are given in 
Table V. 
TABLE V 
Titration of C'4 in Hu and G.P. Complements 
Human  Guinea pig 
Dilution  C'4 titer  Dilution  C'4 titer 
1 to: 
300 
500 
600 
500 
300 
3O0 
200 
500 
300 
200 
unlts  /ml. 
4000* 
5000* 
12,000* 
5000 
3000 
1200~* 
2000* 
2500* 
3000 
2700 
1 to: 
40O 
400 
300 
300 
300 
500 
200 
500 
500 
200 
nnits  /nd. 
5000* 
5OO0 
3O00 
6000 
3O00 
17,000 
4O0O 
70OO 
10,000 
4O0O 
* These values are possibly low, since in these instances optimal amounts of R4 were not 
necessarily used. 
In this case hu R4 was used. 
C~4 titer of hu  and g.p.  "midpieces":-- 
Source 
Hu 
G.p. 
Method of preparation 
Dilution 
Dialysis, pH 5.4 
"  pH 6.6 
"  pH 5.4 
"  pH 6.6 
C~4 titer 
Original C'  M 
unlts/ml,  unils/ml. 
3000  130 
3000  200 
3000  500 
2000  100 
2000  100 
Recovery 
~cr c~# 
4 
10 
2O 
5 
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Most of the C'4 of g.p. as well as hu C' is encountered in the "endpiece":-- 
Source 
Hu E 
~c  c~ 
G,p. E 
cc  ~ 
~t  ~c 
c~  c~ 
Method of preparation 
Dilution 
Dialysis, pH 5.4 
"  pH 6.6 
Dilution 
6 hrs. dialysis, pH 5.4 
Dialysis, pH 5.4 
C'4 titer 
Original C'  E 
units /ml.  unlts  /ml. 
3000  2400 
3000  2400 
3000  2400 
4OO0  2O00 
4000  3200 
6500  3000 
I0,0O0  4000 
Recovery 
per c$#;~ 
80 
80 
8O 
50 
80 
45 
40 
Treatment with zymosan (R3) also reduced the C'4 activity of hu and g.p. 
CP:~ 
Source 
Hu 
G.p, 
C'4 titer* 
Original C' 
5000 
60O0 
5000 
Reagent 
units/ml. 
2O0O 
2000 
2OO0 
Recovery 
p~cent 
40 
35 
4O 
* Only g.p. R4 was used in these titrations.  Titers were the same when 1 or 2 extra units 
of g.p. C'3 were added. 
Although C'4 is  considered a  heat-stable component, an effect  of heating 
sera at 56°C. for different periods was noted:-- 
Hu C'  G.p. C' 
Period heated  C'4 titer  Activity  Period heated  C'4 titer  Activity 
0 
5" 
10 
15 
20 
30 
units/ml. 
3300 
3000 
1500 
800 
600 
130 
per ce~ 
100 
9O 
45 
25 
20 
4 
0 
5* 
I0 
15 
20 
30 
unlts /ml. 
3300 
30OO 
2000 
1300 
50O 
130 
per cesJ 
90 
60 
40 
15 
4 
* Two minutes were added to each heating period for the sample to come to 56°C. after 
immersion in the bath. 
Finally, reagents retaining only the reactivity of C'4 were prepared by treat- 
ing  heat-inactivated hu  and  g.p.  C'  with  zymosan.  With  either  of  these 
reagents, g.p.  R4 gave  complete hemolysis.  When the  g.p.  C'4  was  added 464:  H'U'MAN AND  GUINEA PIG  COMPLEMENTS  AND  COMPONENT  FRACTIONS 
to  the somewhat  anticomplementary  ammonia-  or  hydrazine-treated  hu  C' 
(hu R4)  hemolysis did not  occur.  Replacement  of hu  C'4 by  g.p.  C'4 was 
easily accomplished  (contrary to  (2)),  however, by addition  of g.p.  C' or E, 
which  contain much C'4, to hu R4. 
Since these studies were carried out over a period of years and the methods 
adopted  evolved gradually,  complete data  on  all four  components  of every 
TABLE VI 
Titers of ttu and G.P. Complements and thdr Components 
Source and No.  C'  C'I  C'2  Ct3  C'4 
Individual, hu 
Pool,  "4 
Pool, g.p. 
c¢  c~ 
¢~  cc  8 
unlts/ml. 
70 
100 
80 
100 
100 
300 
500 
270 
300 
400 
uni~/ml. 
2700 
5OOO 
5OO0 
4OOO 
2OOO 
1000 
1300 
1600 
unlts/ral. 
80 
200 
130 
100 
130 
800 
500 
270 
400 
400 
u•¢ts/mI. 
> 130 
350 
350 
250 
>200 
350 
600 
300 
300 
400 
units/ml. 
30OO 
250O 
25OO 
30OO 
2700 
60O0 
17,000 
7000 
4000 
10,000 
TABLE  VII 
A~erage Titers of Complement and Components 
Source  Whole C'  C'l  C'2  C'3  C'4 
units /ml.  units~rot,  unlts  /ml.  units~m1,  units /ral. 
G.p.  350  2300*  450  370  6000 
Hu  100  3700*  170  250  4000 
* Average titer with R1 (g.p. E plus heated g.p. serum), the optimal reagent. 
complement were not obtained.  Some of the more complete sets of titration 
values on individual complements are, however, taken from the various tables 
and given for ready comparison in  Table VI.  Numbers, when assigned,  are 
those given in Table I. 
The average titers found  in  the course of this  study for hu  and  g.p.  sera 
(Tables I, II, IV, and V) are given in Table VII. 
DISCUSSION 
Two principles,  enunciated  by  Hegedtis  and  Greiner  (1),  have  served  as 
guides in the present study of the components of human and guinea pig com- 
plements:  (1)  the titer of a  complement is limited by that of the component O.  G.  BIER,  G.  LEYTON,  M.  M.  MAYER,  AND  M.  HEIDELBERGER  46~ 
present in lowest titer, and  (2)  each of the four components of complement 
may be titrated by making it the component of lowest titer through the addi- 
tion of a  reagent containing an excess of the other three components.  The 
conditions in this way become analogous to  those preferentially employed in 
the  estimation  of other  biologically active  substances.  For  example,  com- 
parisons of enzyme concentrations should be made at relatively high substrate 
concentrations so that the apparent enzyme values obtained are independent of 
substrate  concentration  (20).  Similarly  in  studies  of  blood  clotting,  com- 
ponents other than the one to be measured should be present in excess so that 
the clotting time may vary only as a function of the amount of unknown com- 
ponent in the system. 
The four reagents used in  (1) for the study of the complements of a  large 
number of animal species were prepared from guinea pig complement by stand- 
ard methods: "endpiece" for the titration of C'I, "midpiece" for the titration 
of C~2, g.p. serum from which  C'3 had been removed by the action of snake 
venom for the titration of C'3,  and ammonia-treated g.p.  serum,  lacking in 
C'4, for the titration of C'4.  No definite evidence was given, however, that 
the  amounts  of reagents  used  actually  contained  an  excess  of  the  desired 
components,  or that  they were always  used  below their anticomplementary 
concentrations. 
In  the present study each of the reagents used  was  subjected  to scrutiny 
for its actual titer of the component or components it was expected to furnish, 
and  its  anticomplementary  properties  were  checked  in  order  to  ascertain 
whether or not it might safely be used in concentrations high enough to supply 
the needed  amounts. 
It was soon found that "endpiece" (E), the standard reagent for C'1,  was 
often too deficient in C'3  to provide more than a  limiting titer, so that  this 
remained the component of lowest titer in the mixture and was actually meas- 
ured instead  of C'1.  It is  believed that  this accounts for the finding in  (1) 
that the titer of C'1 in g.p. C' is lower than that of C'2, whereas the present 
studies show the actual titer of C'1  to be very high.  It was also noted that 
"midpiece" (M), the standard reagent for C'2, often failed to yield ameasure 
of this component since it furnished too little C'3, in non-anticomplementary 
quantities, to raise the titer of this component in the test mixture above that 
of Ct2.  M  was often deficient in its content of C'4, as well. 
These defects proved to  be readily remediable by addition  of g.p.  serum 
which had been heated at 56°C. for 20 minutes to all tests for Ctl  and C'2. 
This not only provided an excess of C'3 (and C'4 if not already present), but 
also  greatly  reduced  the  often  appreciable  anticomplementary activity of 
M  prepared  from g.p. serum.  Since human M  was not  anticomplementary 
and  usually  showed  a  considerably  higher  titer  of  C'1  than  did  g.p. M 
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consisted of hu M  4-  heated g.p. serum.  The human E  obtained as a  by- 
product in the preparation of M is difficult to use owing to its low titer of C'2, 
so that for the titration of C~1, g.p. E 4- heated g.p. serum is recommended as 
the reagent (R1). 
It was also found that in the so called "specific inactivation" (11,  p. 424) 
of C~3 by "zymosan" (18,  2) and of C'4 by ammonia or hydrazine the other 
components of  C  I  suffered more  or  less  reduction  as  well.  It  is  therefore 
proposed  to  abandon  the  inaccurate  designation,  "specifically inactivated" 
complements,  and  call these  reagents R3  and  R4,  respectively, numbering 
them, as in R1 and R2, according to the components measured with their aid. 
Although it is a  simple matter to test a  treated serum  or reagent for anti- 
complementary action by its depression of the titer of whole complement, the 
evaluation  of  anticomplementary activity is  not  without  complication.  A 
treated serum or reagent may exert an enhancing action  or an anticomple- 
mentary one, or it may have no effect at all on the titer of C'.  Enhancing 
effects are  attributable  to  the  addition  of  the  component,  or  components, 
present in  lowest titer; i.e.,  the  titer-limiting component.  Both  enhancing 
and anticomplementary effects could, however, exist side by side in the same 
solution, but, of course, only the net effect could be demonstrated.  In such an 
event the reagent might be anticomplementary toward g.p.  C/, for example, 
in  which  C~3  is usually the  limiting component, but  enhancing toward  hu 
C t, in which  C~2 is the component in lowest titer.  This would also explain 
the effect of heated g.p.  C ~ in diminishing the anticomplementary action of 
g.p. M, since C~3 is added and this is the limiting component in g.p. C'.  Pos- 
sibly these circumstances also afford an explanation for the increase in titer 
of the C ~ by heated g.p.  serum.  While this would be expected to increase 
the titer of g.p. C  t, in which Cr3 appears, on the average, to be the component 
of lowest titer (Tables II, IV, VI, and VII), although the titer of C'2 is not 
much higher, the reason for the increase is not so apparent in the case of hu 
C  p,  in which C~2  is  the limiting component.  However,  the  titer  of  C~3  is 
not very much greater  (Table VI).  Since it is stated that C'3 is not fixed 
when C ~ is taken up in hemolysis (21, 13) it is possible that a considerable ex- 
cess  of this  component is  essential for full hemolytic activity, perhaps  by 
driving back dissociation of a  loose combination.  Heated g.p. serum would 
provide such an excess.  Other explanations are, however, possible, and the 
effect of heated serum requires further study. 
Ecker  and  PiUemer  and  their  coworkers  have  independently arrived  at 
acceptance of underlying principles similar to those guiding the present studies,  3 
so that necessary revisions of their published conclusions as to the components 
of complement may be awaited. 
*Private communication from Dr. Ecker.  Cf. also Ecker, E. E., Seifter, S., and Dozois, 
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Throughout the present paper emphasis has been laid on the titers of comple- 
ment and its components.  Since volume units have been used, and not units 
of weight, as, for example, in the quantitative method for whole complement 
(3-7),  the data are purely relative and yield no information as to the actual 
content or  concentration of any  component.  Nor  do  the  titers even yield 
information as to  the relative concentrations of the components, since equal 
quantities of each component are not necessarily required for hemolysis. 
There appears,  therefore,  to  be  ample reason  to adhere  to  the principles 
for the estimation of the components of complement laid down by Hegedtis 
and  Greiner  even  though  these  authors  did  not  themselves  apply  them 
consistently.  While it is believed that this defect has been overcome in the 
present  studies  by  the  introduction  of  adequate  controls,  the  writers  are 
under no illusions as to the absolute values of the titers found, or as to each 
proposed reagent being optimally prepared or optimal for its purpose.  They 
do believe, however,  that building upon the work of Hegedtis and  Greiner, 
they have placed  the estimation of the components of complement upon  a 
rational  basis. 
SUM~ZARY 
1.  Defects in methods previously proposed  for the estimation of comple- 
ment components are: failure to ensure an excess of the desired components and 
failure to ensure absence of anticomplementary effects in the dilution ranges 
used.  Existing data are therefore subject to these uncertainties. 
2.  Methods are proposed  for controlling the adequacy of the  reagent for 
each component, for using it in dilutions below its anticomplementary range, 
and for reinforcing it with necessary components if these are present in in- 
adequate amounts. 
3.  Titrations are given of the four components in human and guinea pig 
complements and in "midpiece,"  "endpiece," and in the various reagents used, 
including one with C'3 reactivity, solely, and one with C'4 reactivity. 
4.  C'3 is shown to be the component which usually limits the titer in guinea 
pig complement, and C'2 the component of lowest titer in human complement. 
5.  In immune hemolysis, each  component  of human  complement may be 
replaced  by  the  corresponding  component  of  guinea  pig  complement and 
vice versa. 
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